Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings 2021-05-27 09:00
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership 2021-05-27 08:30
Gannex Received China IND Approval of Its FXR Agonist ASC42 for NASH Indication 2021-05-27 08:30
TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China 2021-05-26 21:00
Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk Multiple Myeloma, Treatment Challenges and Dual-Targeting CAR-T with Overnight Manufacturing - a Novel Approach for Treatment of Multiple Myeloma 2021-05-26 21:00
RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19 2021-05-26 19:12
Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US 2021-05-26 16:10
I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets 2021-05-26 03:00
OptraSCAN Announces CytoSiA - A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing 2021-05-25 21:27
Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device 2021-05-25 19:02
ViewMind Applauded by Frost & Sullivan for Its One-of-a-Kind Digital Biomarker Technology for Neurocognitive Disorders 2021-05-25 18:47
IVF Life the first clinic group in Europe to use Artificial Intelligence to non-invasively assess the genetic integrity of embryos 2021-05-25 17:15
Renowned international investor Jim Rogers joins Life3 Biotech's Board of Investors 2021-05-25 16:30
Seegene reports solid results in the first quarter of 2021 with KRW 351.8 billion 2021-05-25 15:33
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA 2021-05-25 08:30
Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development 2021-05-25 08:00
SIRONA - The world's first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly 2021-05-25 07:03
Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project 2021-05-25 06:00
TruDiagnostic signs an exclusive license agreement with Duke University to use the DunedinPoAm rate of aging algorithm. 2021-05-24 20:30
Singapore-based HeMo Bioengineering Receives China's NMPA Approval for flagship Afentta(TM) Aspiration Catheter 2021-05-24 20:01
1 242 243 244 245 246 451